Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Svetlana A. Glukhova"'
Autor:
Taras S. Panevin, Roman V. Rozhivanov, Evgeniy G. Zotkin, Anastasia S. Avdeeva, Svetlana I. Glukhova
Publikováno v:
Терапевтический архив, Vol 96, Iss 5, Pp 486-493 (2024)
Aim. To study the frequency of hypogonadism (HG) in men with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) and to evaluate the impact of HG on the course of RA and and concomitant diseases. Materials and meth
Externí odkaz:
https://doaj.org/article/8d7617a90cd34b05a2c52e6588190e5f
Autor:
Tatiana M. Reshetnyak, Fariza A. Cheldieva, Svetlana I. Glukhova, Kamila S. Nurbaeva, Nataliya V. Seredavkina, Mariya V. Cherkasova, Alexander M. Lila, Evgeny L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 62, Iss 4 (2024)
Thrombotic antiphospholipid syndrome (APS) is a condition affecting young people in whom a thromboembolic event occurs in the presence of circulating antiphospholipid antibodies (aPL).The aim of this study was the evaluation of the incidence of recur
Externí odkaz:
https://doaj.org/article/1428993700ed44f597b48a871e1f56c7
Autor:
Fariza A. Cheldieva, Anastasiia A. Shumilova, Mariya V. Cherkasova, Svetlana I. Glukhova, Aleksander M. Lila, Evgeny L. Nasonov, Tatiana M. Reshetnyak
Publikováno v:
Exploration of Immunology, Vol 3, Iss 5, Pp 475-489 (2023)
Aim: The study aims to evaluate the incidence of recurrent thromboses in patients with primary antiphospholipid syndrome (PAPS) and its association with the presence of different antiphospholipid antibodies (aPLs) and known thrombogenic risk factors.
Externí odkaz:
https://doaj.org/article/deca439db8e0417dbb2ad480b606a20b
Autor:
Yulia L. Korsakova, Tatiana V. Korotaeva, Elena Yu. Loginova, Elena E. Gubar, Lyubov D. Vorobyeva, Svetlana I. Glukhova, Evgeny L. Nasonov
Publikováno v:
Терапевтический архив, Vol 95, Iss 5, Pp 404-409 (2023)
Aim. To develop an integral index of psoriatic arthritis (PsA) activity. Materials and methods. 117 patients with PsA (M/F 63/54) were included. Patients age 4411 years, psoriasis (Ps) duration 213153 months, PsA duration 73.478.5 months. Patients
Externí odkaz:
https://doaj.org/article/1f7fcb563af242e0a1c8ab5d6cb93065
Autor:
Tatiana M. Reshetnyak, Tatiana A. Lisitsyna, Fariza A. Cheldieva, Anastasiia A. Shumilova, Svetlana I. Glukhova, Mayya N. Starovoytova, Nataliya V. Seredavkina, Oxana V. Desinova, Zhanna G. Verizhnikova, Evgeny L. Nasonov
Publikováno v:
Терапевтический архив, Vol 95, Iss 5, Pp 410-417 (2023)
Background. The clinical and serologic heterogeneity of systemic lupus erythematosus (SLE) presents challenges for diagnosis, particularly in the earliest stages of the disease when there are insufficient signs to make a reliable diagnosis. Aim. T
Externí odkaz:
https://doaj.org/article/9808fe316e40451bb70011d39d0fe7c8
Autor:
Elena V. Gerasimova, Tatiana V. Popkova, Maria V. Shalygina, Irina G. Kirillova, Daria A. Gerasimova, Svetlana I. Glukhova, Evgeny L. Nasonov
Publikováno v:
Терапевтический архив, Vol 95, Iss 5, Pp 375-379 (2023)
Aim. To evaluate the detection rate of subclinical carotid atherosclerosis in rheumatoid arthritis (RA) patients with low cardiovascular risk (CVR). Materials and methods. The study included 182 RA patients with low CVR (mSCORE1%) and no establish
Externí odkaz:
https://doaj.org/article/a47672898a074e099b076a4c958ac1da
Autor:
Andrey E. Karateev, Elena Iu. Polishchuk, Alena S. Potapova, Elena V. Matyanova, Ekaterina S. Filatova, Svetlana I. Glukhova, Aleksander M. Lila
Publikováno v:
Consilium Medicum, Vol 25, Iss 2, Pp 105-112 (2023)
Background. Slow-acting symptomatic agents (chondroprotectors) in osteoarthritis (OA) combined therapy is a promising approach. Aim. To compare the real-world results of combined therapy with glycosaminoglycan-peptide complex (GPC) and diacerein w
Externí odkaz:
https://doaj.org/article/65155bce773f4829a00a52e2dad9789a
Autor:
Yulia L. Korsakova, Elena Yu. Loginova, Tatiana V. Korotaeva, Elena E. Gubar, Svetlana I. Glukhova, Elizaveta A. Vasilenko, Evgeny L. Nasonov
Publikováno v:
Терапевтический архив, Vol 94, Iss 5, Pp 622-627 (2022)
Background. Psoriatic arthritis (PsA) is a complex immune-mediated disease in which a third of patients with psoriasis (PsO) have a inflammatory lesion of both the musculoskeletal system (peripheral joints and axial structures) and extra-articular ma
Externí odkaz:
https://doaj.org/article/5aa718ec4b2f416ea2cb48c308f275eb
Autor:
Anton A. Abramkin, Tatiana A. Lisitsyna, Dmitry Yu. Veltishchev, Olga F. Seravina, Oksana B. Kovalevskaya, Svetlana I. Glukhova, Evgeny L. Nasonov
Publikováno v:
Терапевтический архив, Vol 94, Iss 5, Pp 616-621 (2022)
Aim. To compare changes in functional limitations in patients with rheumatoid arthritis (RA) and comorbid anxiety and depressive disorders (ADD) treated with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) alone or in combinat
Externí odkaz:
https://doaj.org/article/8b176cfe2e444499ae01ecfff32ae89a
Autor:
Olga A. Krichevskaya, Tatyana V. Dubinina, Ekaterina V. Ilinykh, Svetlana I. Glukhova, Anastasia B. Demina, Irina A. Andrianova
Publikováno v:
Терапевтический архив, Vol 94, Iss 5, Pp 647-653 (2022)
Aim. To assess the dynamics of activity of ankylosing spondylitis (AS) during the year after childbirth, to identify predictors of high activity. Materials and methods. 75 pregnant with confirmed AS (modified New York criteria, 1984) were included
Externí odkaz:
https://doaj.org/article/816e1a2a23e348e6a1cb0f2eb09d04bb